Redeye revises its fair value range upwards after correcting a previous error about the treatment of...
Redeye has revised its fair value range following Vertex's cash offer of SEK36.
We cut '24e-'25e adj. EBIT by 63-36%EBIT recovery delayed into 2024'24e-'25e EV/EBIT 30x-10xTough bu...
Railcare nådde rekordomsättning i Q3 trots betydande problem i sektorn.
Taaleri announced today the second close of its new flagship fund Solar Wind III with EUR 430m of co...
Underleverantör till en cybersäkerhetsaffär Ordern grundar sig i ett samarbete mellan cybersäkerhets...
RanLOS AB (publ) (”RanLOS” eller ”bolaget”) meddelade den 20 december en årlig statusuppdatering öve...
IRLAB Therapeutics has announced that IRL757, a drug candidate being developed for the treatment of ...
Binero proposed a merger with Infrateq in an all-stock deal.
After market close on 21 December, CapMan announced acquisition of Dasos Capital, an asset managemen...
Equity analyst Markus Almerud discusses Maha Energy after the acquisition of an exclusivity to part ...
- IRL757 drug candidate for apathy ready for Ph 1 - Grant from The Michael J.
Substansrabatten ligger långt över det historiska genomsnittet.
Enrad utvecklar, producerar och säljer kylaggregat och värmepumpar för drift med naturliga köldmedie...
Following the focusing of the roadmap after the rights issue in October, Nanexa has now announced a ...
Redeye initiates coverage on Raketech which is a tech-focused affiliate and performance marketing gr...
Evaxion has a new CEO since September and a new focus on business development.
NoHo Partners updates its guidance for 2023. The company now expects its EBIT margin to be above 9.
Edyoutec (”Bolaget”) meddelade fredag den 15 december att Bolaget både signerat ett förvärvsavtal av...
Redeye comments on Fragbite Group's token sales of EUR800k.
